Invention Grant
- Patent Title: RSV F protein compositions and methods for making same
-
Application No.: US17848205Application Date: 2022-06-23
-
Publication No.: US11655284B2Publication Date: 2023-05-23
- Inventor: Kurt Swanson , Philip R. Dormitzer
- Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE Rixensart
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: C07K16/10
- IPC: C07K16/10 ; A61K39/155 ; A61K39/12 ; C07K14/005 ; A61K39/00
Abstract:
The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
Public/Granted literature
- US20220340645A1 RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME Public/Granted day:2022-10-27
Information query
